Skip to main content
Year archive

RHYTHM BIOSCIENCES LIMITED — 2018 filings

All 33 regulatory filings released by RHYTHM BIOSCIENCES LIMITED (RHY) in 2018, sourced directly from the official regulator.

33 Filings
2018 Period
2018 filings (33)
Filing Released Lang
Rhythm Receives R&D Tax Incentive Refund 1 page 75.
Capital/Financing Update
2018-12-10 English
Rhythm Completes Reagent Development Program 2 pages 85.0KB
Capital/Financing Update
2018-12-04 English
Appointment of CEO - Senior Management Changes 17 pages 527.8KB
Board/Management Information
2018-11-27 English
AGM Presentation 14 pages 845.3KB
Investor Presentation
2018-11-25 English
Results of Meeting 1 page 165.1KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-25 English
Change of Director's Interest Notice 3 pages 240.0KB
Director's Dealing
2018-11-13 English
Appendix 4C 8 pages 227.9KB
Interim / Quarterly Report
2018-10-28 English
Notice of Annual General Meeting/Proxy Form 16 pages 412.4KB
AGM Information
2018-10-11 English
Final Antibody Selection Complete 3 pages 99.9KB
Board/Management Information
2018-10-02 English
Appendix 4E 2 pages 37.2KB
Report Publication Announcement
2018-08-30 English
Annual Report 54 pages 1.6MB
Annual Report
2018-08-30 English
Appendix 4G and Corporate Governance Statement 19 pages 208.4KB
Governance Information
2018-08-30 English
Appendix 3B - release from escrow 12 pages 444.3KB
Capital/Financing Update
2018-08-28 English
Change in substantial holding 2 pages 191.4KB
Regulatory Filings
2018-08-12 English
Release of Restricted Securities from Escrow 1 page
Regulatory Filings
2018-08-05 English
Appendix 4C 7 pages 177.7KB
Interim / Quarterly Report
2018-07-29 English
Rhythm completes cloning of key reagent ahead of schedule 2 pages 76.7KB
Regulatory Filings
2018-06-20 English
Merchant Group increases stake in Rhythm from 5% to 7% 3 pages 219.8KB
Major Shareholding Notification
2018-06-14 English
RHY Welcomes Leading Biotech Fund as New Major Shareholder 5 pages 168.8KB
Major Shareholding Notification
2018-06-11 English
Key Management Appointments at Rhythm Biosciences 2 pages 74.1KB
Board/Management Information
2018-05-21 English
Appendix 3B 13 pages 250.3KB
Capital/Financing Update
2018-05-21 English
Rhythm Granted Biomarker Patent in Europe 2 pages 109.7KB
Regulatory Filings
2018-05-15 English
RHY's Four Antibodies Pass all Three Key Screening Tests 2 pages 129.6KB
Regulatory Filings
2018-05-13 English
Appendix 4C 6 pages 226.7KB
Interim / Quarterly Report
2018-04-29 English
Reagent Development Update 2 pages 128.1KB
Capital/Financing Update
2018-04-23 English
Change of Director's Interest Notice 3 pages 182.1KB
Director's Dealing
2018-03-22 English
Appendix 4D - Half Yearly Report 2 pages 33.3KB
Interim / Quarterly Report
2018-02-28 English
Half Yearly Report and Accounts 20 pages 984.1KB
Interim / Quarterly Report
2018-02-26 English
Consultation with Major Diagnostic Labs Underway - Update 2 pages 158.8KB
Regulatory Filings
2018-02-14 English
Rhythm reports reagent development update 2 pages 206.5KB
Capital/Financing Update
2018-02-06 English
Quarterly report and Appendix 4C 7 pages 960.5KB
Interim / Quarterly Report
2018-01-30 English
CSIRO and Rhythm Commence Development of Key Reagents 1
Regulatory Filings
2018-01-23 English
CSIRO to assist Rhythm Biosciences develop key reagents 2 pages 567.5KB
Regulatory Filings
2018-01-08 English